Consolidated Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (56,347)	$ (52,629)
Adjustments to net loss:
Depreciation and amortization	2,484	2,629
Stock-based compensation	1,591	3,404
Goodwill impairment	23,372	25,452
Other asset impairments	20,840	783
Changes in fair value of investments and liabilities	(1,991)	593
Bad debt expense	801	1,607
Loss on disposal of discontinued operations	3,132	0
Interest expense (income)	94	(56)
Interest paid	(94)	(4)
Income tax benefit	(1,617)	(1,538)
Net income (loss) to cash provided by (Used in) operating activities	(7,735)	(19,759)
Net change in non-cash working capital:
Trade and other receivables	1,522	143
Inventory	576	1,219
Prepaid expenses and other assets	(419)	1,372
Trade payables and accrued liabilities	(2,340)	1,090
Net cash used in operating activities	(8,396)	(15,935)
Cash flows from financing activities:
Units issued	2,738	5,000
Equity issue costs	(396)	(520)
Exercise of warrants and options	0	187
Common shares repurchased	0	(255)
Loan borrowings	995	197
Loan repayments	(187)	(196)
Net cash provided by financing activities	3,150	4,413
Cash flows from investing activities:
Purchases of property, plant and equipment and intangible assets	(163)	(1,294)
Net cash on disposal	(71)	0
Business and asset acquisitions, net of cash acquired	0	(14,508)
Net cash used in investing activities	(234)	(15,802)
Effect of exchange rate on changes on cash	930	(755)
Change in cash during the period	(4,550)	(28,079)
Cash and restricted cash at beginning of period	8,935	37,616
Cash included in assets held for sale	0	(602)
Cash and restricted cash at end of period	4,385	8,935
Supplemental disclosure of non-cash investing and financing activities
Common shares issued for business combinations	$ 0	$ 24,712
Common shares issued for other agreements	95	1,470
Operating lease additions to right of use assets	245	2,919